CPHI (China Pharma Holdings, Inc.) Utang jangka cendhak marang modal

China Pharma Holdings (CPHI) is currently in a phase of technological stagnation, limiting itself to formal audits and packaging upgrades. This daily price chart helps track this process, where the indicator stands at 0.10. The company is scaling the production of psychoneurological drugs and branded generics to capture new niches. The supply to medical centers and pharmacies is managed through an extensive network of regional distribution centers.

This ratio compares the volume of liabilities maturing within one year to the amount of equity, allowing for an assessment of liquidity risk and dependence on expensive debt financing. Analyzing the chart of short-term liabilities to equity helps determine the resilience of China Pharma Holdings (CPHI) to market shocks during the period of management adaptation to China's healthcare reforms.